MSL/Sr. MSL Rare Tumors/Heme (Florida/Puerto Rico)
Astellas Pharma
Summary
Identify and evaluate Key External Experts (KEEs) and future medical stakeholders aligned with meeting scientific in alignment with the medical strategy and be the trusted advisor for scientific exchange throughout the product life cycle.
Job description
Purpose & Scope
Identify and evaluate Key External Experts (KEEs) and future medical stakeholders aligned with meeting scientific in alignment with the medical strategy and be the trusted advisor for scientific exchange throughout the product life cycle.
Trusted advisor for scientific exchange to Key External Experts (KEEs) and stakeholders throughout the product life cycle.
Responsible for gathering data from the field that generates medical insights.
Deliver medical/scientific learning solutions to internal stakeholders.
Collaborate effectively with internal stakeholders, within and outside of MA.
Execute and support development of the tactical field plans for engagement with the medical/scientific community for a product.
Role and Responsibilities
Field Medical Leadership
- Support MSL Team Lead in deployment of tactical field plans for engagement with the medical/scientific community and management of overall Astellas business objectives.
- Serve as a coach, mentor, and a role-model for MSLs.
Scientific and Interaction Expertise
- Engage in scientific exchange in which knowledge about product(s), disease(s) and therapeutic areas is shared to ensure safe and effective use of Astellas products.
- Engage in discussions regarding evolving trends in disease state management, trends in therapy.
- Engage external stakeholders in one-on-one interactions and group settings, demonstrating an excellent scientific and clinical knowledge as well as an understanding of stakeholder needs.
- Maintain medical and scientific knowledge and staying current to enable peer-to-peer scientific exchange.
- Demonstrates high level of proficiency in interpersonal skills to engage effectively with a range of internal and external stakeholders.
Qualifications
Required Qualifications
- MD, PhD, PharmD, DNP in health related sciences.
- Minimum of 3-5 years in scientific/medical experience in research-based pharmaceutical industry with minimum 2-3 years of experience working in Medical Affairs.
Key competencies
- Scientific exchange excellence
- Medical insight generation
- Interpersonal relationships
- Learning agility
- Business-fluent English
Location and Working Environment
- This position is based in field based and requires 60-70% travel
Requirements
- MD, PhD, PharmD, DNP in health related sciences
- Minimum of 3-5 years in scientific/medical experience in research-based pharmaceutical industry
- Minimum 2-3 years of experience working in Medical Affairs
- Scientific exchange excellence
- Medical insight generation
- Interpersonal relationships
- Learning agility
- Business-fluent English
Benefits
- Medical, Dental & Vision
- Paid Time Off
- 401(k) match
- Life insurance
- Annual Corporate Bonus
- Quarterly Sales Incentive
- Long Term Incentive Plan
- Company fleet vehicle
- Referral bonus program
Company overview
Astellas Pharma Inc. is a leading Japanese multinational pharmaceutical company headquartered in Tokyo, Japan. Founded in April 2005 through the merger of Yamanouchi Pharmaceutical (established 1923) and Fujisawa Pharmaceutical (established 1894), Astellas has grown into a global life sciences company with operations in more than 70 countries worldwide. The company employs approximately 14,500 people globally and generates annual revenues exceeding $12 billion. Astellas is committed to turning innovative science into value for patients through transformative therapies in key therapeutic areas including oncology, ophthalmology, urology, immunology, and women's health. The company's notable products include Xtandi for prostate cancer, Padcev for bladder cancer, Xospata for acute myeloid leukemia, Veozah for menopausal symptoms, and Izervay for geographic atrophy. With a strong focus on research and development, Astellas invests approximately 17% of its sales revenue into pioneering new healthcare solutions for diseases with high unmet medical needs. The company operates multiple research centers in Japan, the United States, and Europe, and has established strategic partnerships and acquisitions to expand its pipeline and capabilities in areas such as gene therapy and immuno-oncology.